Cargando…
The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q)
INTRODUCTION: The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q) created a research infrastructure to recruit, characterize, and track disease progression in individuals at risk of dementia. METHODS: CIMA-Q established standardized clinical, neuropsychological, n...
Autores principales: | Belleville, Sylvie, LeBlanc, Andréa C., Kergoat, Marie-Jeanne, Calon, Frédéric, Gaudreau, Pierrette, Hébert, Sébastien S., Hudon, Carol, Leclerc, Nicole, Mechawar, Naguib, Duchesne, Simon, Gauthier, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880140/ https://www.ncbi.nlm.nih.gov/pubmed/31788534 http://dx.doi.org/10.1016/j.dadm.2019.07.003 |
Ejemplares similares
-
A quadratic function of activation in individuals at risk of Alzheimer's disease
por: Corriveau‐Lecavalier, Nick, et al.
Publicado: (2021) -
Theoretical frameworks and approaches used within the Reserve, Resilience and Protective Factors professional interest area of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment
por: Bartrés‐Faz, David, et al.
Publicado: (2020) -
Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020) -
Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment
por: Zammit, Andrea R., et al.
Publicado: (2015) -
Traits of patients who screen positive for dementia and refuse diagnostic assessment
por: Fowler, Nicole R., et al.
Publicado: (2015)